Oral Abstract Session:
44. Adult and Adolescent Vaccines
Thursday, October 4, 2018: 10:30 AM-11:45 AM
Room: S 158

Tracks: Adult ID, Pediatric ID


Moderators:  H. Keipp Talbot, MD, MPH, Vanderbilt University Medical Center and Nadine Rouphael, MD, FIDSA, Emory University

Presentations:
10:30 AM
149
Immunogenicity, Safety and Post-hoc Efficacy Assessment of the Adjuvanted Recombinant Zoster Vaccine in Adults with Hematologic Malignancies: A Phase 3, Randomized Clinical Trial
Alemnew F. Dagnew, MD, MSc; Osman Ilhan, MD; Won-Sik Lee, MD, PhD; Dariusz Woszczyk, MD, PhD; Jae-Yong Kwak, MD, PhD; Stella Bowcock, MA, MBBS; Sang Kyun Sohn, MD; Gabriela Rodriguez Macías, MD; Tzeon-Jye Chiou, MD; Dimas Quiel, MD; Mickael Aoun, MD; Maria Belen Navarro Matilla, MA, MBBS; Javier De La Serna, MD; Samuel Milliken, MBBS FRACP FRCPA; John Murphy, MB; Shelly A. McNeil, MD, FIDSA; Bruno Salaun, PhD; Emmanuel Di Paolo, MSc; Laura Campora, MD; Marta López-Fauqued, PhD; Mohamed El Idrissi, MSc; Anne Schuind, MD; Thomas C. Heineman, MD, PhD; Peter Van Den Steen, PhD; Lidia Oostvogels, MD
10:45 AM
150
Relative Effectiveness of High-Dose and Standard-Dose Influenza Vaccine Against Influenza-Related Hospitalization Among Older Adults — United States, 2015–2017.
Joshua Doyle, MD/PhD; Lauren Beacham, MApStat; Elif Alyanak, MPH; Manjusha Gaglani, MBBS; Emily T. Martin, MPH, PhD; Don Middleton, MD; Fernanda P. Silveira, MD, MS; H. Keipp Talbot, MD, MPH; Richard Zimmerman, MD, MPH; Brendan Flannery, PhD; Jill M. Ferdinands, PhD, MSc
11:00 AM
151
Evaluation of pneumococcal vaccine effectiveness against invasive pneumococcal disease among U.S. Medicare beneficiaries >=65 years old
Tamara Pilishvili, MPH, PhD; Olivia M. Almendares, MSPH; Srinivas Nanduri, MBBS, MD, MPH; Rob Warnock, BA; Xiyuan Wu, MS; Stephen McKean, PhD; Jeffrey Kelman, MD MMSc; Monica M. Farley, MD, FIDSA; William Schaffner, MD, FIDSA, FSHEA; Ann Thomas, MD, MPH; Arthur Reingold, MD, FIDSA; Lee H. Harrison, MD; Corinne Holtzman, MPH; Jemma V. Rowlands, MPH; Susan Petit, MPH; Meghan Barnes, MSPH; Salina Torres, MPH; Bernard Beall, PhD; Cynthia Whitney, MD, MPH, FIDSA
11:15 AM
152
Protective Antibody Levels 7.5 Years after Primary Vaccination in Adolescence with a Recombinant, 4-Component, Meningococcal Serogroup B Vaccine (4CMenB) and Response to a Booster Dose in Adolescents and Young Adults: Phase IIIb Clinical Findings
Terry Nolan, MBBS PhD; Miguel O'Ryan, MD; María Elena Santolaya, MD; Ferdinandus De Looze, MBBS FRACGP MSc; Helen Marshall, MD MBBS MPH; Peter Richmond, MBBS FRACP; Sam Henein, MD; Paul Rheault, MD, CCFP; Ken Heaton, MD; Kirsten Perrett, MBBS FRACP PhD; Hartley Garfield, MD; Anil Gupta, MD CCFP FCFP; Murdo Ferguson, Mb.ChB, CCFP(EM) FCFp Dip Sport Med(Can); Diego D'Agostino, MSc; Daniela Toneatto, MD
11:30 AM
153
The Effect of Timing of Tetanus-diphtheria and Pertussis Vaccine Administration in Pregnancy on The Avidity of Pertussis Antibodies
Bahaa Abu Raya, MD; Michelle Giles, MD; Tobias Kollmann, MD, PhD; Manish Sadarangani, BM, BCh, DPhil

CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.